LISDEXAMFETAMINE 50 MG TB CHEW

Lisdexamfetamine Dimesylate
$4.9357per EA
DEA Schedule CII

Strength

50 mg/1

Manufacturer

SpecGx LLC

NDC

00406512801

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218850

On Market Since

12/17/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-1.4%

3M

-6.0%

6M

-17.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

-28.4%